268 related articles for article (PubMed ID: 11776859)
1. [Surgical treatment of ovarian malignant tumors metastasized to the gastro-intestinal tract: a report of 131 cases].
Peng Z; Pan X; Liu H
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):142-4. PubMed ID: 11776859
[TBL] [Abstract][Full Text] [Related]
2. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
[TBL] [Abstract][Full Text] [Related]
6. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, diagnosis and treatment of hepatic metastasis of pure immature ovarian teratoma.
Fan Q; Huang H; Lian L; Lang J
Chin Med J (Engl); 2001 May; 114(5):506-9. PubMed ID: 11780414
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 57 patients with ovarian dysgerminoma].
Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
[TBL] [Abstract][Full Text] [Related]
9. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
[TBL] [Abstract][Full Text] [Related]
10. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
11. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
[TBL] [Abstract][Full Text] [Related]
12. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
Li YF; Li MD; Liu FY; Liu JH; Li JD
Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
[TBL] [Abstract][Full Text] [Related]
13. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
[TBL] [Abstract][Full Text] [Related]
14. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
[TBL] [Abstract][Full Text] [Related]
15. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognostic factors of malignant ovarian teratoma].
Jin FM; Zhu GZ; Feng YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
[TBL] [Abstract][Full Text] [Related]
17. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
19. [Surgical resection for gastrointestinal metastatic melanoma].
Dequanter D; Sales F; Legendre H; Lothaire P; Pector JC
Ann Chir; 2004 Jun; 129(5):278-81. PubMed ID: 15220101
[TBL] [Abstract][Full Text] [Related]
20. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]